Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules.

Clin Neuropharmacol · 2019 · PMC7654938 · PMID 30520758

Europe PMC DOI

hedged sentence

0.0601

closest p · 1.2× alpha

0.0601

boldest claim

The sentences

did not reach statistical significanceP = 0.0601so close (0.05 < p ≤ 0.1)

IPX203 showed significant differences compared with Rytary from 5 to 10 hours (all P ≤ 0.0352) except at 7 hours where the improvement did not reach statistical significance ( P = 0.0601).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.